OncoCyte Corporation Profile Avatar - Palmy Investing

OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test fo…

Biotechnology
US, Irvine [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of OCX's Analysis
CIK: 1642380 CUSIP: 68235C107 ISIN: US68235C2061 LEI: - UEI: -
Secondary Listings
OCX has no secondary listings inside our databases.